The investment of state funding in three companies will help support San Antonio medical jobs (Click here).

State officials recently announced that the Texas Emerging Technology Fund will invest a total of $9.2 million in three companies that are planning to relocate from California to San Antonio.

The companies, which are branching out from InCube Labs, will use the funding to develop and commercialize treatments that help patients suffering from iron-deficiency anemia, epilepsy, and atrial fibrillation. They will work with the the Texas A&M Institute for Preclinical Studies to develop the treatments.

"Texas continues to be a leader in jobs, innovation and technological development, thanks in part to investments through the Texas Emerging Technology Fund, which have attracted top researchers and cutting edge companies to the state," Gov. Rick Perry said. "InCube's three spin-out companies have the potential to develop groundbreaking treatments for some of the most common and most challenging medical conditions we are faced with today."

The three companies that will receive funding from TETF include:

• Neurolink Medical Inc. - $3.2 million to develop an implant device that can predict seizures and treat underlying diseases through intracranial drug delivery.Epilepsy affects 3 million people in the United states and about 50 million people throughout the world.
• Corhythm Inc. - $3.1 million to develop an implant treatment that can detect early onset atrial fibrillation and chronic heart failure. The device uses semiconductor technology and materials science to provide pacing and defibrillation and deliver drugs when an atrial fibrillation is detected.
• Fe3 Medical Inc. - $2.8 million to commercialize a drug delivery technology that enables the safe, non-toxic transport of iron across the skin of those who suffer from iron-deficiency anemia. Of the 24 million Americans who suffer from iron-deficiency anemia, about 30 to 40 percent cannot take oral iron supplements.